TABLE 4.

Outcome measures under alternative payment systems

			Base model	MYHC adjustor	MYHC pooling	MYLC adjustor	MYLC constraint	MYHC adjustor & MYLC adjustor	MYHC pooling & MYLC constraint
Reduction in incentives for cost control compared to base model			‐	17.2%	22.9%	8.1%	0%	25.3%	18.9%
Payment System Fit (PSF)			0.249	0.268	0.493	0.250	0.248	0.270	0.480
Cummings Prediction Measure (CPM)			0.249	0.268	0.371	0.258	0.246	0.277	0.339

	Prev.	Mean costs	Mean financial result in Euros per person per year
Malignant neoplasm blood other	0.07%	20,674	−6427	−6141	−2996	−6522	−5985	−6109	−2843
Leukemia	0.12%	14,983	−3942	−3969	−2644	−3980	−3610	−3920	−2523
Malignancy NOS	0.04%	12,963	−3212	−2823	−1910	−3245	−2856	−2786	−1842
Limited function/disability (d)	0.03%	8779	−2300	−1354	−290	−2302	−2029	−1281	−317
Congen.anom. blood/lymph other	0.04%	7145	−2175	−1802	−1282	−2146	−2038	−1726	−1245
Hypertension uncomplicated	13.68%	4182	−159	−158	−174	−151	82	−128	80
Osteoarthrosis of knee	2.97%	5344	−580	−466	−461	−569	−253	−426	−156
Cardiovascular disease other	1.75%	6550	−932	−792	−548	−964	−612	−765	−297
Diabetes	6.10%	5915	−255	−205	−206	−274	130	−185	180
Chronic obstructive pulmonary disease	2.72%	6955	−569	−520	−517	−696	−178	−495	−135
Voluntary deductible = 100 euro	0.78%	1182	157	154	161	131	77	105	76
Voluntary deductible = 200 euro	0.77%	863	250	256	256	208	145	187	143
Voluntary deductible = 300 euro	0.45%	821	270	276	283	217	160	197	163
Voluntary deductible = 400 euro	0.13%	821	296	311	316	238	187	226	196
Voluntary deductible = 500 euro	5.34%	602	317	327	333	257	182	238	186
Weighted mean absolute result (WMAR) of 15 groups shown above			343	313	295	343	188	273	156

Note: Spending is presented in euros per person per year. Prevalence is calculated as a percentage of total insured years in the population and (rebalanced) sample.